top of page
Nelson Advisors > European HealthTech & MedTech


Nelson Advisors featured in Forbes: 5 High-Growth Business Models Set To Thrive In The Coming Decade
Nelson Advisors thought leadership has been referenced in the Forbes article '5 High-Growth Business Models Set To Thrive In The Coming Decade' outlining five business models that are primed for success in the coming years.
Nelson Advisors
Oct 10, 2025


Defence MedTech: New market emerging combining defence innovation and medical technology
The intersection between defense innovation and medical technology (MedTech) represents a fundamental structural shift, moving beyond simple technological spillovers to establish a mutually reinforcing economic and R&D ecosystem. Military Research and Development (R&D) functions as a highly accelerated, high-stakes validation engine, forcing the creation of exceptionally robust, autonomous, and efficient medical capabilities required for assured care in austere and contested
Nelson Advisors
Oct 10, 2025


This Week in European HealthTech and MedTech: 5th October 2025
The major stories in the world of European MedTech this week are dominated by regulatory activity under the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), a significant European Commission "Call for Evidence" for future reforms, and fresh funding for companies focused on connected and remote monitoring devices.
Nelson Advisors
Oct 5, 2025


The Future of MedTech: Building Value for Strategic Acquisitions
The MedTech mergers and acquisitions (M&A) landscape is undergoing a profound and irreversible transformation. The traditional playbook, which long emphasised incremental product improvements and narrowly focused acquisitions, has become largely obsolete. A new era has emerged, defined by the strategic convergence of medical technology, data intelligence, and consumer-centric care models.
Nelson Advisors
Aug 20, 2025
bottom of page